It’s more than just a timing issue. Regardless of where Intel directed its capital expenditures, the core purpose of CapEx is to expand and support the company’s manufacturing capacity. Intel spent an enormous
$123.92 billion in CapEx from 2020 to 2025, or
$94.867 billion from 2021 to 2024 alone. Yet during this period, Intel’s revenue began a multi‑year decline, net profit turned into net losses, and the company started burning cash a lot faster than it could generate it.
View attachment 4100
Is Intel telling the truth? Certainly. But is Intel presenting the full picture? I don’t believe it is.
For example, did Intel shift some expenses into CapEx, something that is completely legal, to make other numbers look better? That could be one of the reasons why Intel’s reported CapEx appears huge but ineffective, even if it is technically within accounting rules.
Beginning in January 2023, Intel shifted to an eight‑year depreciation schedule for its fab equipment, replacing the previous five‑year schedule, while TSMC continues to use a five‑year schedule. Even with this substantial reduction in depreciation expense compared with the old method, Intel still can’t generate a profit.
How can a company that spent
$123.92 billion in CapEx and
$93.545 billion in R&D from 2020 to 2025 end up with shrinking revenue, net losses, and negative free cash flow in a market that’s booming? Even worse, according to last week’s earnings call, Intel admitted it still can’t produce enough of the products customers actually want to buy, despite six years of massive capital spending. Something is very wrong.